Search filters

List of works by Daniel L Hertz

Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer

scientific article

Challenges to assess substrate-dependent allelic effects in CYP450 enzymes and the potential clinical implications

scientific article published on 15 October 2019

Comparison of eight screening tools to detect interactions between herbal supplements and oncology agents

scientific article published on 19 February 2020

Concerns regarding use of patient-reported outcomes in biomarker studies of chemotherapy-induced peripheral neuropathy

scientific article published on 09 August 2019

DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses

scientific article published on 29 July 2020

ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors

scientific article published on 19 August 2016

Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole

scientific article published on 01 June 2019

Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships

scientific article published on 06 January 2021

Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathy

scientific article published on 23 July 2020

Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy

scientific article published on 10 December 2019

Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses

scientific article

Germline Pharmacogenetics of Paclitaxel for Cancer Treatment ⬇️

scientific article published on July 1, 2013

Germline genetic variants with implications for disease risk and therapeutic outcomes

scientific article

Osteonecrosis of the Jaw Risk Factors in Bisphosphonate Treated Patients with Metastatic Cancer

scientific article published on 04 December 2020

Paclitaxel Plasma Concentration After the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy.

scientific article published on 27 April 2018

Patients carrying DPYD variant alleles have increased risk of severe toxicity and related treatment modifications during fluoropyrimidine chemotherapy

scientific article published on 07 January 2021

Pharmacogenetics, Enzyme Probes and Therapeutic drug Monitoring as Potential Tools for Individualizing Taxane Therapy ⬇️

scientific article published on April 1, 2013

Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy

article

Pilot study of rosiglitazone as an in vivo probe of paclitaxel exposure ⬇️

scientific article published on July 1, 2012

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials

scientific article published on 22 November 2018

Tamoxifen and CYP2D6: A Contradiction of Data ⬇️

scientific article published on April 24, 2012

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity ⬇️

scientific article published on May 16, 2013

Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy

scientific article published on 12 March 2020

Paulina is supported by:

About Paulina

Help